top of page
Website - Cover image_edited.jpg

Our Mission

PulseMedica is laser-focused on improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease.

Backed by Leading Investors
White_Logo.png

Our Story

PulseMedica's Founding Story

PulseMedica’s story began when Dr. Nir Katchinskiy completed his PhD under the supervision of Prof. Abdulhakem Elezzabi at the University of Alberta. Their research focused on femtosecond laser-tissue interaction.

 

In 2020, Nir participated in the Creative Destruction Lab - Rockies (CDL-R) program where he met Eric Martin, who was pursuing his MBA at the University of Alberta.

 

United by their commitment and passion for enacting change for those suffering from eye disease, Abdul, Nir, and Eric co-founded PulseMedica with invaluable guidance and support from CDL-R mentors.

Leadership at PulseMedica

We believe that leadership isn't just a position but a commitment to inspiring, innovating, and empowering others to achieve success. Meet the leadership team at PulseMedica: Nir Katchinskiy, Eric Martin, and Thas Yuwaraj.

Meet The PulseMedica Team

Joe (2).jpg
Joe (2).jpg
Joe (2).jpg
Joe (2).jpg
Joe (2).jpg
Joe (2).jpg

What We Strive For

Short-Term Vision

Screen and Treat Symptomatic Eye Floaters
Become the global expert in non-invasive, safe, effective imaging and treatment of floaters.

Long-Term Vision

Address Additional Vitreoretinal Eye Disease
Become the global standard for screening and treating vitreoretinal disease.
White Waves_edited.jpg

PulseMedica Partners

PulseMedica has gained the support of Provincial, Federal and international partners. Thank you for your continued support!

Recent News About PulseMedica

2024

PulseMedica Raises $12 Million CAD to Advance Eye Floater Imaging and Treatment Technology

PulseMedica Raises $12 Million CAD to Advance Eye Floater Imaging and Treatment Technology

by Alberta Innovates

2024

AICE Validate Funded Projects

by University of Alberta

2024

Investing in the Next Generation of Entrepreneurs and Innovators

by RBCx

2024

Founder Insights: How Life Sciences Startups Can Acquire Funding
bottom of page